Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicinal composition for treatment of hepatitis

A composition and technology of traditional Chinese medicine, applied in the field of traditional Chinese medicine composition for the treatment of hepatitis, can solve problems such as high recurrence rate, long treatment cycle, inability to treat both symptoms and root causes, and achieve remarkable effects, no toxic side effects, and good therapeutic effect

Active Publication Date: 2013-05-15
CP PHARMA QINGDAO CO LTD
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the research and application of traditional Chinese medicine for the treatment and prevention of hepatitis are extensive, the curative effect of traditional Chinese medicine for the treatment of hepatitis is not significant, the effect is single, the pertinence is poor, the treatment cycle is long, the recurrence rate is high, and it cannot treat both the symptoms and the root causes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicinal composition for treatment of hepatitis
  • Traditional Chinese medicinal composition for treatment of hepatitis
  • Traditional Chinese medicinal composition for treatment of hepatitis

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0030] Observation object and method

[0031] 1. Case selection

[0032] (1) Etiological diagnosis

[0033] Type A: Those who have any one of the following four items:

[0034] 1. Serum anti-HAVIgM positive in patients with acute hepatitis;

[0035] 2. The anti-HAVIgG titer of the double serum in the acute phase and the recovery phase increased by more than 4 times;

[0036] 3. HAV particles were detected by anti-HAV immuno-electron microscopy in feces in the early acute stage;

[0037] 4. HAAg was found in feces in the early acute stage.

[0038] Type B: Those who have any one of the following four items:

[0039] 1. Serum HbsAg positive, or HbeAg positive;

[0040] 2. Serum HbsAg positive, but anti-HbcIgM positive, or anti-HBs, or anti-HBc positive;

[0041] 3. Serum HBV-DNA or DNA polymerase positive, or HbeAg, or anti-Hbe positive;

[0042] 4. The indicators of HBV infection are not obvious or only one indicator of anti-HBc is positive, while HbcAg, HbsAg or HBV-DN...

experiment example 2

[0118] Experimental Example 2: Pharmacodynamics Experiment

Embodiment 1

[0132] Embodiment 1 capsule

[0133] Kelp extract 3kg Eucheuma extract 1kg

[0134] Fenugreek 50kg Geranium 30kg.

[0135] Add 15 times the amount of water to fenugreek and geranium, soak for 36 hours; decoct twice with a slow fire, the first time for 2 hours, filter out the medicinal liquid for later use, add 10 times the amount of water for the second time, and cook with a slow fire Decoct for 1 hour, filter the medicinal liquid for use; combine the secondary medicinal liquid and filter, collect the filtrate; concentrate the filtrate to a thick paste with a relative density of 1:1.25-1.35, bake the thick paste at a low temperature for 10 hours, and dry it Paste powder, according to dry paste powder: mix dry paste powder with kelp extract and Eucheuma extract; add excipients at a weight ratio of 1:0.5 to starch, granulate, dry at 50°C, granulate and pack into capsules middle. Capsule specification: 0.2g / capsule, 3 times a day, 1 capsule each time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a traditional Chinese medicinal composition for treatment of hepatitis. The composition consists of a Laminaria japonica Aresch extract, an Eucheuma extract, fenugreek and Geranium wilfordii. The traditional Chinese medicinal composition provided in the invention is a clinically acceptable tablet, capsule, granule, pill or oral liquid prepared by adding a conventional auxiliary material according to a conventional process. The traditional Chinese medicinal composition disclosed in the invention has liver soothing and liver protecting functions, can achieve good therapeutic effects on acute hepatitis A, acute hepatitis B, chronic persistent hepatitis and chronic active hepatitis, and also has obvious effects and no toxic or side effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating hepatitis, a preparation method and a new application thereof. Background technique [0002] Hepatitis includes acute and chronic hepatitis, chronic persistent hepatitis and chronic active hepatitis. It is a common and frequently-occurring disease, especially the liver disease caused by hepatitis B virus, which seriously endangers people's health. It is easy to develop into liver cirrhosis and even transform into liver cancer. Liver disease, especially hepatitis B, is one of the most common infectious diseases in the world. According to relevant reports, nearly 1 million people die each year due to liver disease. my country is a country with a high incidence of liver disease. At present, there are about 30 million patients with chronic hepatitis B. And 120 million hepatitis B virus carriers, accounting for more t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/48A61P1/16A61P31/14A61P31/20
CPCY02A50/30
Inventor 王明刚任莉陈阳生
Owner CP PHARMA QINGDAO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com